Skrip, Laura A.
Weller, Malcom B.
Dukuly, Sheikh
Candy, Neima
Harmon-Gray, Wahdae-Mai
Clarke, Adolphus
Dahn, Bernice T.
Funding for this research was provided by:
Sabin Vaccine Institute,United States (050169-00, 050169-00, 050169-00, 050169-00, 050169-00)
Article History
Received: 20 October 2023
Accepted: 12 March 2024
First Online: 1 April 2024
Declarations
:
: The study protocol was reviewed and approved by the University of Liberia Institutional Review Board (ULIRB IORG-IRB Number: IRB00013730). The study conformed to the principles outlined in the Declaration of Helsinki. Study participants were assigned unique identification numbers used in the survey form and on the in-depth interview transcripts to protect identities. All participants provided verbal consent before data collection via phone and were made aware that they could choose to end the survey or interview at any time or skip questions they felt uncomfortable answering. Participants were provided funds via mobile money after the surveys and interviews to facilitate calling the study team with questions or concerns at a later date.
: Verbatim quotes from the in-depth interview transcripts are reflected in the manuscript. Identifying information has been removed from each quote. The use of direct quotes in published materials was provided as part of the consent process for the interview participants.
: The authors declare that they have no competing interests.